IRCT2015080223470N1
Completed
Phase 2
Comparison of Haloperidol and Opium Tincture in the control of clinical signs associated with methamphetamine
Vice Chancellor for Research, University of Medical Sciences0 sites70 target enrollmentStarted: TBDLast updated:
Overview
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Vice Chancellor for Research, University of Medical Sciences
- Enrollment
- 70
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •Dependence on methamphetamine (more than 10 times the regular use of methamphetamine or 10 days); Urine tests positive for methamphetamine; Age 18\-65 years; Independence and no use of drugs or other addictive drugs at the time of presentation; Complete the consent form; To track patient;
- •Exclusion criteria: Unwillingness person to continue treatment; Patient self\-medication or participate in another study; Other addictive drugs or alcohol or drug use during the study period; Non\-compliance with medication orders during the study; Coming out of treatment (imprisonment, death, ...); Any behavior that resulted in dismissal laws rehab clinic patient; There are other mental disorders that require treatment or the risk of suicide; Significant diseases of the Thyroid, Kidney, Liver, Gastrointestinal or Cardiovascular; History of diabetes or Heart attack, Seizures, Glaucoma, Tick, Tardive dyskinesia; Female without adequate contraception pregnancy or lactation; Tincture of opium abusers; A history of allergy to Haloperidol; Simultaneous treatment with antipsychotics or mood stabilizers or CYP 2D6 inhibitors Contains: Amiodarone, Bupropion, Celecoxib, Cimetidine, Chlorpromazine, Clomipramine, Fluoxetine, Haloperidol, Methadone, Moclobemide, Paroxetine, Quinidine, Ritonavir, Sertraline, Terbinafine and Thioridazine; So dangerous side effects of medications or the patient is intolerable.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 3
Comparative study of the effect of haloperidol and dexmedetomidine on Restlessness in mechanically ventilated patients following concussion admitted to the intensive care unit of Imam Khomeini HospitalIRCT20200803048288N1Ahvaz University of Medical Sciences60
Completed
Phase 2
The comparison of analgesic effect of haloperidol plus morphin with morphin alone in patients with acute renal colic presenting to emergency departmentrilothiasis.Calculus of kidney and ureterIRCT2015092224136N1Vice challencor for reasearch of Ahvaz Jundishapur University of Medical Sciences140
Completed
Phase 3
Opium trialopioid dependence.Mental and behavioural disorders due to use of opioidsIRCT201506261556N78Tehran University of Medical Sciences240
Completed
Not Applicable
Role of Haloperidol and Olanzapine in the treatment of DeliriumHealth Condition 1: null- DeliriumCTRI/2016/10/007331Government Medical College Hospital100
Recruiting
Phase 3
Haloperidol effect on postoperative delirium prophylaxisDelirium.Other deliriumF05.8IRCT20080830001127N8Tabriz University of Medical Sciences180